在骨质疏松症高危患者中，特立帕肽治疗后的序贯治疗。
Sequential therapy following teriparatide treatment in patients at high risk of osteoporotic patients.
作者信息
Mori Satoshi
机构信息
Department of Bone and Joint Surgery, Osteoporosis Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
出版信息
J Bone Miner Metab. 2025 Jan;43(1):22-25. doi: 10.1007/s00774-025-01584-0. Epub 2025 Mar 22.
PMID:40119935
Abstract
The use of medications in sequence is recommended in several osteoporosis guidelines to afford the best protection for the patient at very high risk of fracture. Sequential therapy following once-weekly as well as daily teriparatide treatment is a potent option for those patients.
摘要
在多个骨质疏松症指南中，推荐序贯使用药物，以便为骨折高风险患者提供最佳保护。对于这些患者而言，在每周一次以及每日一次的特立帕肽治疗之后进行序贯治疗是一种有效的选择。
Zotero 插件